MD6 and Robert J. Fox Archives - 2021 CMSC Annual Meeting

2021 CMSC Annual Meeting

Tag: MD6 and Robert J. Fox

Poster-Disease-modifying Therapy

October 25, 2021

Safety and Efficacy of Siponimod in Patients with Active Secondary Progressive Multiple Sclerosis Identifying As Hispanic from the Expand Study

Background: In the Phase 3 EXPAND trial siponimod, a selective S1P receptor modulator, significantly reduced risk of 3-month and 6-month...

Read More →

MAILING ADDRESS

3 University Plaza Drive, Ste 116
Hackensack, NJ 07601

CONTACT US

(201) 487-1050
info@mscare.org

FOLLOW US

© 2021 CMSC